Quick Takeaways: Why It Matters? LIMPID’s acquisition of PetPeotalk turns Kinfora into a richer, behaviour‑driven pet health platform, because it brings in a mature vision‑AI stack (Dogibogi) with real‑world scale, hundreds of millions of labelled behaviour ...
Quick Takeaways: Why It Matters? Medgene’s launch could be a meaningful de-risking event for cattle producers because it creates the first U.S. prescription vaccine option for a parasite with severe herd-level consequences and no approved treatment, potentially reducing losses from mortali...
Quick Takeaways: Why It Matters? Zoetis’s Portela launch should expand the feline OA market by turning a hard-to-manage, underdiagnosed condition into a more actionable treatment segment, especially because the therapy offers a three-month injectable option that is easier for owners to kee...
Quick Takeaways: Why It Matters? Credelio Quattro appears to have a clear speed-of-kill advantage over Simparica Trio and NexGard Plus, with the studies showing faster and more sustained tick kill through the full monthly dosing interval. That matters because quicker tick death lowers the ...
Quick Takeaways: Why It Matters? CVS’s move to dispense pet prescriptions at roughly 9,000 pharmacies effectively turns it into a mass‑market veterinary pharmacy, expanding access to common dog and cat medications and creating a new recurring revenue stream built on refills, syncing, and e...
Featured Article Understanding Pet Food Labels: What Every Pet Owner Should Know Cover Story Investment Product Launch Product Expansion Partnership Clinical Study Regulatory Updates Zoetis Acquires VitalRADS Acquisition Zoetis has agreed to acquire VitalRADS to expand its veterinary diagn...
Quick Takeaways: Why It Matters? The EUA makes ivermectin liquid a short-term, horse-only screwworm prophylaxis tool, adding another regulated option to the NWS armamentarium and slightly strengthening biosecurity for foals and wounded horses, but because protection lasts only 24 hours and...
Quick Takeaways: Why It Matters? Zoetis’s launch of Lenivia (izenivetmab) in Canada and the EU introduces the first long-acting monoclonal antibody for canine osteoarthritis that binds a different NGF site than existing anti‑NGF therapies, offering up to three months of pain relief from a ...
Quick Takeaways: Why It Matters? Royal Canin’s Fresh Veterinary Diets give veterinarians a fresh, fully cooked therapeutic option in a fast-growing US therapeutic dog food market, aligning medical nutrition with owner demand for “fresh” feeding and strengthening Royal Canin’s position agai...
Quick Takeaways: Why It Matters? Tevra’s expansion of the Vetality First Aid Collection pushes more vet‑style OTC care into mainstream retail, making it easier for pet owners to treat common problems quickly at home and likely increasing self-care product sales and category growth at Walma...
